Diving with psychotropic medication: review of the literature and clinical considerations

Diving Hyperb Med. 2023 Sep 30;53(3):259-267. doi: 10.28920/dhm53.3.259-267.

Abstract

This review discusses the safety concerns associated with diving while using psychotropic medication and the limited literature available on the topic. Despite the risks, some divers continue to dive while taking these medications, and their reasons for doing so are unclear. The exact mechanisms of action of these drugs in hyperbaric environments are poorly understood. While current standards and advice for fitness-to-dive assessments are based on limited evidence and expert opinion, developing evidence-based strategies could improve patient care and optimise diving safety. This review appraises relevant literature in diving medicine and provides clinical perspectives for diving physicians conducting fitness-to-dive assessments on patients using psychotropic medication.

Keywords: Fitness-to-dive; Medications; Mental health; Pharmacology; Psychiatry; Scuba.

Publication types

  • Review

MeSH terms

  • Diving* / adverse effects
  • Exercise
  • Humans